0000899243-21-025975.txt : 20210625
0000899243-21-025975.hdr.sgml : 20210625
20210625170032
ACCESSION NUMBER: 0000899243-21-025975
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210623
FILED AS OF DATE: 20210625
DATE AS OF CHANGE: 20210625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mayweg Alexander
CENTRAL INDEX KEY: 0001786260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40522
FILM NUMBER: 211048783
MAIL ADDRESS:
STREET 1: C/O VERSANT VENTURES, AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc.
CENTRAL INDEX KEY: 0001826457
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 645 SUMMER STREET
STREET 2: SUITE 102
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-949-2643
MAIL ADDRESS:
STREET 1: 645 SUMMER STREET
STREET 2: SUITE 102
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-23
0
0001826457
Monte Rosa Therapeutics, Inc.
GLUE
0001786260
Mayweg Alexander
MONTE ROSA THERAPEUTICS, INC.
645 SUMMER STREET, SUITE 102
BOSTON
MA
02210
1
0
0
0
Stock Option (Right to Buy)
19.00
2021-06-23
4
A
0
47132
0.00
A
2031-06-22
Common Stock
47132
47132
D
This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on June 28, 2021.
/s/ Ajim Tamboli, Attorney-in-Fact
2021-06-25